Skip to content

Released May 4, 2023, after the close

10-Q filed May 4, 2023, 34 days after period end · 0000950170-23-017931

Q1 2023 · 10-Q
Revenue$0.00no prior Q1 2022 on fileno prior Q4 2022 on file
Net Income-$18.95MN/M vs Q1 2022N/M vs Q4 2022
EPS Diluted-$4.46N/M vs Q1 2022no prior Q4 2022 on file
Operating Income-$19,559,000N/M
Operating Cash Flow-$23,428,000N/M
Free Cash Flowderived-$23,428,000N/M

What the release said

The release

Same quarter

MetricQ1 2023Q1 2022Q1 2021Q1 2020
Revenue$0.00——$4.08M
Net Income-$18.95M-$23.09M-$27.20M-$26.66M
EPS Diluted-$4.46-$0.48-$0.69-$0.76

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR